Older people who take daily low-dose aspirin have at 20% higher risk of developing anemia even without having already had a major bleeding event, according to results from a new randomized controlled trial.
In the study, which was published June 20 in the Annals of Internal Medicine, investigators analyzed data from the Aspirin in Reducing Events in the Elderly (ASPREE) and examined hemoglobin concentrations among 19,114 healthy, community-dwelling older patients.
Share This Post